{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:38:44Z","timestamp":1787168324537,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,31]]},"DOI":"10.7759\/cureus.23687","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:06:52Z","timestamp":1648735612000},"source":"Crossref","is-referenced-by-count":13,"title":["Opportunistic Infections in COVID-19: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Nithin","family":"Kurra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka Isaac","family":"Woodard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhila","family":"Gandrakota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasa Rao","family":"Polisetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Peng","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinjalben P","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwaj","family":"Chitimalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirza M","family":"Ali Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayathri","family":"Samudrala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Modes of transmission of virus causing COVID-19. implications for IPC precaution recommendations. (2020). Accessed: February 26, 2022: https:\/\/www.who.int\/news-room\/commentaries\/detail\/modes-of-transmission-of-virus-causing-covid-19-implications-for-ip...."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25748","article-title":"Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures","volume":"92","author":"Wang Y","year":"2020","unstructured":"Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020, 92:568-76. 10.1002\/jmv.25748","journal-title":"J Med Virol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.194139","article-title":"Bacterial coinfection in influenza: a grand rounds review","volume":"309","author":"Chertow DS","year":"2013","unstructured":"Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. JAMA. 2013, 309:275-82. 10.1001\/jama.2012.194139","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens DM","year":"2008","unstructured":"Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008, 198:962-70. 10.1086\/591708","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-020-1668-5","article-title":"Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients","volume":"63","author":"Lin D","year":"2020","unstructured":"Lin D, Liu L, Zhang M, et al.. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients. Sci China Life Sci. 2020, 63:606-9. 10.1007\/s11427-020-1668-5","journal-title":"Sci China Life Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25953","article-title":"Coinfection in SARS-CoV-2 infected patients: where are influenza virus and rhinovirus\/enterovirus?","volume":"92","author":"Nowak MD","year":"2020","unstructured":"Nowak MD, Sordillo EM, Gitman MR, Paniz Mondolfi AE. Coinfection in SARS-CoV-2 infected patients: where are influenza virus and rhinovirus\/enterovirus?. J Med Virol. 2020, 92:1699-700. 10.1002\/jmv.25953","journal-title":"J Med Virol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.12.20022327","article-title":"Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan","author":"Wang M","year":"2020","unstructured":"Wang M, Wu Q, Xu W, et al.. Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan. medRxiv. 2020, 10.1101\/2020.02.12.20022327","journal-title":"medRxiv"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a015669","article-title":"Opportunistic infections--coming to the limits of immunosuppression?","volume":"3","author":"Fishman JA","year":"2013","unstructured":"Fishman JA. Opportunistic infections--coming to the limits of immunosuppression?. Cold Spring Harb Perspect Med. 2013, 3:a015669. 10.1101\/cshperspect.a015669","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251170","article-title":"Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis","volume":"16","author":"Musuuza JS","year":"2021","unstructured":"Musuuza JS, Watson L, Parmasad V, Putman-Buehler N, Christensen L, Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. PLoS One. 2021, 16:e0251170. 10.1371\/journal.pone.0251170","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton B","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, et al.. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015, 162:777-84. 10.7326\/M14-2385","journal-title":"Ann Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins JP","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003, 327:557-60. 10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05374-z","article-title":"Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU","volume":"20","author":"Sharifipour E","year":"2020","unstructured":"Sharifipour E, Shams S, Esmkhani M, et al.. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infect Dis. 2020, 20:646. 10.1186\/s12879-020-05374-z","journal-title":"BMC Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.10.-020504","article-title":"SARS-CoV-2-related pneumonia cases in pneumonia picture in Russia in March-May 2020: secondary bacterial pneumonia and viral co-infections","volume":"10","author":"Sharov KS","year":"2020","unstructured":"Sharov KS. SARS-CoV-2-related pneumonia cases in pneumonia picture in Russia in March-May 2020: secondary bacterial pneumonia and viral co-infections. J Glob Health. 2020, 10:020504. 10.7189\/jogh.10.-020504","journal-title":"J Glob Health"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.31645.2","article-title":"The clinical impact of bacterial co-infection among moderate, severe and critically ill COVID-19 patients in the second referral hospital in Surabaya","volume":"10","author":"Asmarawati TP","year":"2021","unstructured":"Asmarawati TP, Rosyid AN, Suryantoro SD, et al.. The clinical impact of bacterial co-infection among moderate, severe and critically ill COVID-19 patients in the second referral hospital in Surabaya. F1000Res. 2021, 10:113. 10.12688\/f1000research.31645.2","journal-title":"F1000Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.07.041","article-title":"Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study","volume":"27","author":"Garcia-Vidal C","year":"2021","unstructured":"Garcia-Vidal C, Sanjuan G, Moreno-Garc\u00eda E, et al.. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021, 27:83-8. 10.1016\/j.cmi.2020.07.041","journal-title":"Clin Microbiol Infect"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.10.021","article-title":"Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors","volume":"27","author":"Ripa M","year":"2021","unstructured":"Ripa M, Galli L, Poli A, et al.. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. 2021, 27:451-7. 10.1016\/j.cmi.2020.10.021","journal-title":"Clin Microbiol Infect"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00090-2","article-title":"Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study","volume":"2","author":"Russell CD","year":"2021","unstructured":"Russell CD, Fairfield CJ, Drake TM, et al.. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. Lancet Microbe. 2021, 2:e354-65. 10.1016\/S2666-5247(21)00090-2","journal-title":"Lancet Microbe"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-021-00526-y","article-title":"Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia","volume":"9","author":"S\u00f8gaard KK","year":"2021","unstructured":"S\u00f8gaard KK, Baettig V, Osthoff M, et al.. Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia. J Intensive Care. 2021, 9:10. 10.1186\/s40560-021-00526-y","journal-title":"J Intensive Care"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03417-0","article-title":"Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease","volume":"24","author":"Razazi K","year":"2020","unstructured":"Razazi K, Arrestier R, Haudebourg AF, et al.. Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease. Crit Care. 2020, 24:699. 10.1186\/s13054-020-03417-0","journal-title":"Crit Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1298","article-title":"A national strategy to diagnose coronavirus disease 2019-associated invasive fungal disease in the intensive care unit","volume":"73","author":"White PL","year":"2021","unstructured":"White PL, Dhillon R, Cordey A, et al.. A national strategy to diagnose coronavirus disease 2019-associated invasive fungal disease in the intensive care unit. Clin Infect Dis. 2021, 73:e1634-44. 10.1093\/cid\/ciaa1298","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-020-00819-1","article-title":"Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis","volume":"9","author":"Li J","year":"2020","unstructured":"Li J, Wang J, Yang Y, Cai P, Cao J, Cai X, Zhang Y. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis. Antimicrob Resist Infect Control. 2020, 9:153. 10.1186\/s13756-020-00819-1","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-021-00845-5","article-title":"Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations","volume":"65","author":"Bayram N","year":"2021","unstructured":"Bayram N, Ozsayg\u0131l\u0131 C, Sav H, et al.. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations. Jpn J Ophthalmol. 2021, 65:515-25. 10.1007\/s10384-021-00845-5","journal-title":"Jpn J Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238825","article-title":"Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: results from the prospective AspCOVID-19 study","volume":"16","author":"Lahmer T","year":"2021","unstructured":"Lahmer T, Kriescher S, Herner A, et al.. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: results from the prospective AspCOVID-19 study. PLoS One. 2021, 16:e0238825. 10.1371\/journal.pone.0238825","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myab009","article-title":"COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City","volume":"59","author":"V\u00e9lez Pintado M","year":"2021","unstructured":"V\u00e9lez Pintado M, Camiro-Z\u00fa\u00f1iga A, Aguilar Soto M, Cuenca D, Mercado M, Crabtree-Ramirez B. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City. Med Mycol. 2021, 59:828-33. 10.1093\/mmy\/myab009","journal-title":"Med Mycol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13219","article-title":"Prevalence of opportunistic invasive aspergillosis in COVID-19 patients with severe pneumonia","volume":"64","author":"Segrelles-Calvo G","year":"2021","unstructured":"Segrelles-Calvo G, Ara\u00fajo GR, Llopis-Pastor E, et al.. Prevalence of opportunistic invasive aspergillosis in COVID-19 patients with severe pneumonia. Mycoses. 2021, 64:144-51. 10.1111\/myc.13219","journal-title":"Mycoses"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2020.12.008","article-title":"Invasive Aspergillosis associated with Covid-19: a word of caution","volume":"51","author":"Gouzien L","year":"2021","unstructured":"Gouzien L, Cocherie T, Eloy O, et al.. Invasive Aspergillosis associated with Covid-19: a word of caution. Infect Dis Now. 2021, 51:383-6. 10.1016\/j.idnow.2020.12.008","journal-title":"Infect Dis Now"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.12.051","article-title":"EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count","volume":"104","author":"Paolucci S","year":"2021","unstructured":"Paolucci S, Cassaniti I, Novazzi F, et al.. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count. Int J Infect Dis. 2021, 104:315-9. 10.1016\/j.ijid.2020.12.051","journal-title":"Int J Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1812437","article-title":"Risks and features of secondary infections in severe and critical ill COVID-19 patients","volume":"9","author":"Zhang H","year":"2020","unstructured":"Zhang H, Zhang Y, Wu J, et al.. Risks and features of secondary infections in severe and critical ill COVID-19 patients. Emerg Microbes Infect. 2020, 9:1958-64. 10.1080\/22221751.2020.1812437","journal-title":"Emerg Microbes Infect"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-04142-w","article-title":"Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome","volume":"40","author":"Bardi T","year":"2021","unstructured":"Bardi T, Pintado V, Gomez-Rojo M, et al.. Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome. Eur J Clin Microbiol Infect Dis. 2021, 40:495-502. 10.1007\/s10096-020-04142-w","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa530","article-title":"Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study","volume":"76","author":"Falcone M","year":"2021","unstructured":"Falcone M, Tiseo G, Giordano C, et al.. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study. J Antimicrob Chemother. 2021, 76:1078-84. 10.1093\/jac\/dkaa530","journal-title":"J Antimicrob Chemother"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2020.10.014","article-title":"Profile of co-infections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: Implication on antimicrobial resistance","volume":"39","author":"Khurana S","year":"2021","unstructured":"Khurana S, Singh P, Sharad N, et al.. Profile of co-infections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: Implication on antimicrobial resistance. Indian J Med Microbiol. 2021, 39:147-53. 10.1016\/j.ijmmb.2020.10.014","journal-title":"Indian J Med Microbiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab201","article-title":"Characterization of bacterial and fungal infections in hospitalized patients with coronavirus disease 2019 and factors associated with health care-associated infections","volume":"8","author":"Kubin CJ","year":"2021","unstructured":"Kubin CJ, McConville TH, Dietz D, et al.. Characterization of bacterial and fungal infections in hospitalized patients with coronavirus disease 2019 and factors associated with health care-associated infections. Open Forum Infect Dis. 2021, 8:ofab201. 10.1093\/ofid\/ofab201","journal-title":"Open Forum Infect Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.11.135","article-title":"Predictors and outcomes of healthcare-associated infections in COVID-19 patients","volume":"104","author":"Kumar G","year":"2021","unstructured":"Kumar G, Adams A, Hererra M, et al.. Predictors and outcomes of healthcare-associated infections in COVID-19 patients. Int J Infect Dis. 2021, 104:287-92. 10.1016\/j.ijid.2020.11.135","journal-title":"Int J Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/89271-opportunistic-infections-in-covid-19-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:24Z","timestamp":1707507384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/89271-opportunistic-infections-in-covid-19-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.23687","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,31]]}}}